| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|---|
Gross Sales | 670.55 | 520.29 | 400.94 | 228.67 | 146.04 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 670.55 | 520.29 | 400.94 | 228.67 | 146.04 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 15.61 | 2.81 | 1.65 | 0.52 | 0.14 |
Total Income | 686.16 | 523.1 | 402.59 | 229.19 | 146.18 |
Total Expenditure | 490.61 | 386.53 | 290.13 | 161.66 | 108.46 |
PBIDT | 195.55 | 136.57 | 112.46 | 67.53 | 37.71 |
Interest | 9.42 | 21.39 | 21.49 | 18.84 | 18.91 |
PBDT | 186.13 | 115.19 | 90.97 | 48.68 | 18.8 |
Depreciation | 29.3 | 27.51 | 27.87 | 20.56 | 21.29 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 40.77 | 25.93 | 19.81 | 3.37 | 0 |
Deferred Tax | 1.59 | -4.02 | -0.87 | 5.16 | -0.44 |
Reported Profit After Tax | 114.48 | 65.77 | 44.16 | 19.59 | -2.05 |
Minority Interest After NP | 0 | 0 | 0 | 1.43 | -0.75 |
Net Profit after Minority Interest | 114.48 | 65.77 | 44.16 | 18.16 | -1.3 |
Extra-ordinary Items | 0 | 0 | 0 | 0 | 0 |
Adjusted Profit After Extra-ordinary item | 114.48 | 65.77 | 44.16 | 18.16 | -1.3 |
EPS (Unit Curr.) | 14.46 | 10.09 | 6.78 | 11.09 | -0.8 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 85.85 | 65.52 | 65.52 | 16.38 | 16.38 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 29.16 | 26.24 | 28.04 | 29.53 | 25.82 |
PBDTM(%) | 27.75 | 22.13 | 22.68 | 21.28 | 12.87 |
PATM(%) | 17.07 | 12.64 | 11.01 | 8.56 | -1.4 |
The QIP shares were at ₹595 per share which was 5% lower compared with the floor price of ₹626.
The strategic purchase intends to increase Yatharth Hospital's presence in the Delhi-NCR region, hence increasing its regional footprint.
This strategic acquisition is intended to strengthen Yatharth Hospital's presence in the Delhi-NCR region and expand its reach to serve a larger population.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
